Radiation Extends PFS in Recurrent Oligometastatic Prostate Cancer Radiation Extends PFS in Recurrent Oligometastatic Prostate Cancer

High-dose, precision radiation therapy extends progression-free survival in recurrent prostate cancer with limited metastatic spread and prevents the development of new lesions at 6 months.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news